Objective: The purpose of this study is to externally validate a recently reported Vascular Study Group of New England (VSGNE) risk predictive model of postoperative mortality after elective abdominal aortic aneurysm (AAA) repair and to compare its predictive ability across different patients' risk categories and against the established risk predictive models using the Vascular Quality Initiative (VQI) AAA sample.
More and more asymptomatic patients with abdominal aortic aneurysms (AAAs) are diagnosed with AAA while undergoing imaging studies for unrelated reasons. 1 These patients are then confronted with the prospect of a major vascular operation despite the lack of symptoms related to the AAA. Population studies report postoperative mortality rates of 1% to 5% perioperative mortality rate 2, 3 after AAA although with increased use of endovascular AAA repair (EVAR) the mortality rate of AAA repair has decreased significantly. 3, 4 In multiple publications, it has been established that demographic factors, comorbidities, and intraoperative details significantly affect mortality rates after elective AAA repair. [3] [4] [5] [6] [7] [8] [9] [10] Other factors that have shown an association with mortality after AAA include hospital volume, 11 the region where these procedures were performed, 12, 13 and the surgeon's specialty and volume.
14 Understanding one's individual risk for perioperative mortality is important to most patients, particularly upon discovery of an asymptomatic AAA. Risk predictive models can help patients to understand such risks and guide both patient and surgeon in clinical decision making. They also allow for risk-adjusted comparison of outcomes among different surgeons and hospitals. A number of established risk predictive models for elective and symptomatic AAA repair have been developed. [3] [4] [5] [6] 8, 10, 15 We recently reported a robust risk predictive model of in-hospital mortality after elective AAA using a Vascular Quality Initiative (VQI) database from the Vascular Study Group of New England (VSGNE) that performed better than other established models. 3 Grant et al 7 recently evaluated these established models on the United Kingdom National Vascular Database, and noted that both the Medicare 6 and Vascular Governance
Northwest models 8 performed well. The main shortcoming of both of these models is the lack of external validation in an entirely independent sample of patients by different groups of surgeons and even across different geographic regions where both indications and outcomes after AAA have shown to be different.
12,13
The purpose of this study was to externally validate the VSGNE AAA risk predictive model on the VQI patients after removing the cases that were performed by the VSGNE providers. We strove to evaluate whether the VSGNE AAA risk predictive model performs as well in this external sample and how this model predicts the observed mortality rates across different risk quintiles of the VQI. We then compared the discriminative ability of this model against three established models.
METHODS
Details of the VSGNE and the VQI databases are previously published and widely available. The VSGNE is a regional cooperative database created in 2002 to prospectively collect data on patients who undergo vascular procedures with the aim of improving regional outcomes in vascular surgery. 16 Since its inception, the database has expanded to include more than 35 academic and community hospitals. 17 Data are collected prospectively by trained nurses or clinical abstractors on more than 100 clinical and demographic variables. The VQI was launched in 2010 18 based on the success of the VSGNE and currently includes 401 centers in 46 US states and Ontario and is composed of 16 collaborative regional centers that prospectively collect data on index vascular procedures including procedures for AAA. 19 Similarly, the purpose of the VQI, is to "provide benchmark reports" to the participating centers and surgeons to improve the quality of vascular care. 18 3 To simplify the use of the risk algorithm in clinical practice, we developed a simple scoring scheme based on the final logistic regression model using the method described by Sullivan et al. 20 The details of the VSGNE AAA model are described in our previous publication and parameters and risk scores assigned to these variables are provided in Table I . 3 The cohorts used in this study included all elective AAA procedures in the VSGNE and the VQI databases. Patients with prior aortic surgery, and urgent and emergent procedures were excluded from this analysis. Descriptive analyses were performed on the entire cohort comparing the VSGNE AAA cohort against the VQI cohort after removing VSGNE cases. Henceforth, any referral to the VQI sample in this report and these Recommendation: This study offers external validation and suggests that the VSGNE predictive score can reasonably predict early mortality following abdominal aortic aneurysm repair, more accurately than other scoring systems.
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analyses refers to this VQI cohort after removal of the VSGNE cases. In the VQI sample, we also analyzed if there was significant difference between the VQI sample patients who survived and those who died across the eight risk variables in the VSGNE AAA risk predictive model and whether there was an association between these variables and mortality in the VQI sample. We used the Student t test (continuous variables) and c 2 test (categorical variables) for these descriptive analyses.
The VSGNE model discrimination in determining in-hospital mortality after elective AAA on the VQI sample was evaluated by determining the area under the curve (AUC) of the receiver operating characteristics as described by Hanley and McNeil. 21 The calibration of the model was assessed via Hosmer-Lemeshow test. 22 The prediction strength of the model was further investigated by computing risk scores for each VQI patient using beta weights from the VSGNE AAA model. We then gathered these scores into risk quintiles and examined the association of calculated mortality in risk quintiles with observed in-hospital postoperative mortality to evaluate if the VSGNE model could predict the mortality across different risk categories of this external independent sample. We also evaluated the risk point distribution in the VQI sample and compared the means of the two samples.
Model comparison with other established models. Of the currently established models, three models were chosen based on the availability of clinical variables collected in the VQI to calculate predicted mortality among the VQI patients. These three models included the Glasgow Aneurysm Score, 10 Medicare model, 6 and Vascular Group of Northern Wales model. 8 The variables in the models chosen here are all recorded in the VQI and the VSGNE databases. The discrimination of each risk model was assessed in the VQI cohort via the AUC of the receiver operating characteristics curves. The discriminatory ability of these different models were tested against each other using Akaike-adjusted Vuong closeness-of-fit test. 23 All data analyses were performed 
RESULTS
Descriptive analyses. We identified 4431 elective AAA cases in the VSGNE database from 2003 to 2012. This cohort was used in the derivation of the VSGNE model. 3 The external validation cohortdthe VQI sampled included 16,989 cases. The descriptive comparison of the two samples is depicted in Table II . There were significant differences between the two cohorts (Table II) . These differences are not unidirectional; some were significantly higher and some were significantly lower in the VQI compared with the VSGNE (Table II) . Mortality rates were significantly different between the two cohorts with the mortality rates significantly lower in the VQI sample (0.9% vs 1.4%; P < .05). Compared with the VSGNE sample, there was also significantly lower use of open infrarenal AAA repair (both infrarenal and suprarenal clamp positions) and significantly higher use of EVAR among the VQI cases (Table II) . The higher use of endovascular repair in the VQI sample is probably one reason for the higher mortality rate in the VSGNE sample. The VSGNE sample includes 2003 through 2012, where the use of EVAR increased from 45% to 78% indicating significant increase in use of EVAR (P < .05). 3 In the VQI sample that includes 2010 through 2015, EVAR use increased from 79% to 84.2%, but this was not statistically significant.
A comparison of the group who survived vs those who died after elective AAA in the VQI sample demonstrates that the patients who died were more likely female, older, and among patients with peripheral vascular disease, chronic obstructive pulmonary disease, congestive heart failure, cerebrovascular disease, elevated creatinine, and those who had aneurysms that were larger than 65 mm (Fig 1) . These components of the VSGNE AAA risk predictor model showed significant univariate association with mortality in the VQI sample. Applying the point scoring system from the VSGNE AAA model 3 (Table I) , the mean risk point score for the VQI was 2.6, which was significantly less than the risk point distribution in the derivation (VSGNE) sample (mean, 3.18; P < .05). The point distribution of risk scores in two samples is depicted in Fig 2. 
EXTERNAL VALIDATION OF THE VSGNE AAA MODEL ON THE VQI COHORT
The VSGNE AAA model, as well as the three other risk predictive models, was then applied to the VQI sample (Fig 3) . The VSGNE model performed the best with very good predictive ability of mortality after elective AAA in this external independent sample. The AUC for the receiver operating curves of the VSGNE applied to the VQI was 0.802, indicating strong discriminative ability of this model to predict in-hospital mortality in this independent sample. Hosmer-Lemeshow goodness of fit showed good correspondence of the predicted and The frequency of these risk factors was significantly higher in patients who died. Abnl, Abnormal (ie, creatinine >1.5 mg/dL); COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; CVD, cerebrovascular disease; PVD, peripheral vascular disease. expected mortality (P ¼ .329). When compared with the other models, the discriminative ability of the VSGNE model was significantly higher than the other models (Fig 3) . Akaike-adjusted Vuong tests that allow one-to-one comparison of the non-nested models yielded a significant fit difference favoring the VSGNE model compared with the other models. Specifically, the VSGNE model performed significantly better than Medicare, Vascular Governance Northwest, and Glasgow Aneurysm Score models (P ¼ .014, P ¼ .049, and P ¼ .003, respectively).
Dividing the VQI sample according to risk categories based on risk quintiles estimated by the VSGNE model, the VSGNE model predicted in-hospital mortality very closely across all 5-risk categories of the VQI sample. As shown in Fig 4 , the predicted mortality calculated by the VSGNE model closely approximated the observed mortality across all risk groups from the lowest to the highest risk groups of the VQI sample.
DISCUSSION
Our study shows that the VSGNE AAA risk predictor model of mortality can predict with great accuracy the postoperative in-hospital mortality (AUC, 0.802) in a significantly different independent group of patients who underwent elective AAA repair in the VQI sample. The predictive ability of this simple risk predictive model is significantly more accurate than the other established models in that it can closely predict outcomes in the entire sample and across all patient risk categories.
There are several reasons why an individualized calculation of periprocedural risks may be important to a patient who is undergoing an elective AAA. During discussion with patients who are offered elective AAA for asymptomatic AAA, we often rely on large studies to describe the periprocedural risk of mortality. These population based "mortality rates" often have no tangible meaning to a patient who is to undergo surgery and Fig 2. Point distribution of the Vascular Study Group of New England (VSGNE) abdominal aortic aneurysm (AAA) cohort using the point scoring system (red) and the point distribution of the Vascular Quality Initiative (VQI) AAA cohort (black). Both distribution curves seem to be skewed to the right with an average point score of 3.18 for the VSGNE cohort and an average point score of 2.6 for the VQI cohort (P < .05). does not factor in the patient's individual comorbidities. Using a risk predictive model can better inform patients of their individual risk of mortality and may be a useful tool in obtaining informed consent for the procedure. Additionally, because outcomes after AAA repair have become indicators of inpatient quality measures, 24 such risk scores and models may allow for appropriate hospitals and surgeon outcome comparisons. These elements are the reasons that a robust parsimonious model is indicated in predicting mortality after elective AAA repair. Established risk predictor models are often internally validated [3] [4] [5] [6] [7] [8] [9] [10] and, although the predictive ability of these models may be acceptable, without external validation of the model on an independent database, these model are criticized as biased toward the sample that was used in the derivation of the model. 25 In this study, we showed that the VSGNE model demonstrated a high degree of predictability in forecasting adverse outcomes in an independent (external) sample. The discriminative ability, as shown by the AUC of the receiver operating characteristic curves, is very high and is close to the predicative ability of the model applied internally to the VSGNE AAA sample (AUC, 0.812). 3 Because the differences between the derivation and the validation samples are vast and include comorbidities, type of procedures, and mean risk points, this AUC is indeed impressive. Importantly, the predictive ability of the VSGNE model was strong across all the risk categories of this independent sample. All the contemporary models include the choice of open surgery as an important risk factor for elective surgery. Additionally, numerous publications document the significant increase in the use of EVAR over the past 15 years. Future attempts to design risk predictive models should be directed to developing models that uniquely predict adverse outcomes among patients who undergo EVAR. Because the mortality rate among patients undergoing EVAR is low, the ratio of events per variables in the model is low. This often leads to "model overfitting" 27 and the development of such models requires special biostatistical methods. 28 Although we are currently in the process of developing such a model, the VSGNE model adequately and accurately predicts postoperative mortality in the VQI sample that includes 83.4% EVAR procedures with very high discriminative ability. Taken together, we believe that this model has good predictability for both open and endovascular cases. In addition to the three described established models that were compared with the VSGNE, there are other models that have been used for predicting mortality after AAA. 4, 5, 9, 29, 30 These models each have several variables that are not collected in the VQI and therefore were not included in the comparison against the VSGNE model. Additionally, the VSGNE model includes only perioperative variables and does not include variables that are recorded intraoperatively, such as blood loss or lowest blood pressure, which is recorded in the AAA SCORE model. 5 Although intraoperative variables can be used in risk-adjusted comparison of outcomes, they have no value in preoperative risk discussions with a patient. In comparison with the other three models, the VSGNE model predicts mortality significantly more accurately and across all different risk categories. A table summarizing the comparison of the VSGNE and the variables in some of the other models that only include preoperative variables in their model is presented in another of our publications. 4 In addition to the type of procedure previously discussed, advanced age, elevated creatinine or abnormal kidney function, and female sex are all significant predictors of adverse outcomes after AAA repair in all these models. [3] [4] [5] [6] 8, 9, 29, 30 According to the VSGNE model, the risk score for an elderly ($75 years of age) female patient with abnormal creatinine who is undergoing EVAR is between 6 and 10 points depending on the degree of creatinine elevation or abnormality. 3 The same model calculates the probability of mortality between of 2.9% and 20.75%, 3 which is 3.2 to 23.1 times higher than the observed mortality rates in the entire VQI sample that includes open procedures. In such a patient, the usefulness of aneurysm repair should be balanced carefully against the inherent risks. The VSGNE model provides a simple method to calculate these risks and to educate patients. We are in the process of developing a handheld device application that can be used easily in preoperative risk discussions with patients with an AAA. The external validation of the model here shows that this model is robust in predicting mortality after elective AAA repair.
There are limitations to this analysis. This retrospective analysis carries a certain degree of bias inherent to any retrospective analysis. Prospective application of this model to patients undergoing AAA repair ultimately will provide a better methodology to evaluate the discriminative capability of this model. This analysis also depends on the quality of the data entered and there are certain variables that may not have been entered reliably, such as the exact AAA size or creatinine levels. It is difficult to ascertain if such errors play any role in the conclusions drawn from this analysis. However, because this database is audited vigorously, we believe that the data are robust for this type of analysis and the outcome of interest, mortality, is always reliably coded. Other limitations may have to do with the VSGNE model, such as a lack of predictability beyond the index admission and lack of certain important perioperative variables, such as patient's functional status in the model. Future modifications to the VSGNE model may overcome these limitations. Despite these limitations, we believe that the conclusions drawn from this study are sound. It needs to be mentioned that, despite the robustness of the VSGNE model, there is room for improvement of this model. To improve the predictability of the model, it may be reasonable to adjust the variables used (eg, using a continuous age variable instead of categorical age variable of above or less than 75 as used here) or add other variables that are not included in this model (eg, the Frailty Index). In addition to this, other regression models may yield better predictability of the model. Future research is warranted to improve the predictability of this model and we are pursuing some of these methodologies to improve this model further.
CONCLUSIONS
The VSGNE AAA risk predictive model shows very strong discriminative capability in predicting postoperative mortality after elective AAA in an independent sample of patients who underwent AAA repair by a variety of surgeons across the United States. Both internally and now externally validated, this simple VSGNE AAA risk predictive model provides a reliable method of calculating the probability of an individual patient's mortality after elective AAA with high degree of accuracy. This risk predictive model should be used in perioperative discussions with the patients who are undergoing elective AAA repair to better guide patients' decisions and to better allow for risk-adjusted comparison of outcomes and appropriate resource use for patients who are considered high-risk patients.
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